机译:外周血干细胞与G-CSF单独与G-CSF和环磷酰胺在多种骨髓瘤中的环磷酰胺和地塞米松诱导后的G-CSF和环磷酰胺。
Clinical Haematology Austin Health Heidelberg VIC Australia;
Clinical Haematology Austin Health Heidelberg VIC Australia;
Clinical Haematology St Vincent's Health Fitzroy VIC Australia;
Integrated Haematology Department Peter MacCallum Cancer Centre and Royal Melbourne Hospital;
Integrated Haematology Department Peter MacCallum Cancer Centre and Royal Melbourne Hospital;
Integrated Haematology Department Peter MacCallum Cancer Centre and Royal Melbourne Hospital;
Integrated Haematology Department Peter MacCallum Cancer Centre and Royal Melbourne Hospital;
Clinical Haematology Cancer Services Barwon Health- University Hospital Geelong VIC Australia;
Clinical Haematology Cancer Services Barwon Health- University Hospital Geelong VIC Australia;
Integrated Haematology Department Peter MacCallum Cancer Centre and Royal Melbourne Hospital;
Integrated Haematology Department Peter MacCallum Cancer Centre and Royal Melbourne Hospital;
Clinical Haematology Alfred Health-Monash University Clayton VIC Australia;
Department of Haematology Monash University Eastern Health Clinical School Clayton VIC Australia;
Department of Haematology Monash University Eastern Health Clinical School Clayton VIC Australia;
Clinical Haematology Austin Health Heidelberg VIC Australia;
机译:外周血液干细胞通过单独的G-CSF与G-CSF和环磷酰胺在多发性骨髓瘤中的环磷酰胺和地塞米松诱导后与G-CSF和环磷酰胺一起致动。
机译:地塞米松,紫杉醇,依托泊苷,环磷酰胺(d-TEC)和G-CSF用于多发性骨髓瘤的干细胞动员。
机译:多发性骨髓瘤患者使用Plerixafor和G-CSF与Cyclophosphamide和G-CSF进行自体外周血干细胞动员的成本和结果分析:鉴于环磷酰胺成本增加,需要重新评估
机译:HPLC-ESI -MS / MS分析人外周血淋巴细胞和HAPMAP细胞中环磷酰胺的DNA加合物
机译:抗TNF治疗与原发性神经系统血管炎患者的类固醇环磷酰胺联合治疗
机译:墨西哥儿童中G-CSF与环磷酰胺加G-CSF的干细胞动员
机译:具有多骨瘤患者的基磷脂和G-CSF与G-CSF与G-CSF与环磷酰胺和G-CSF的成本和结果分析:鉴于环磷酰胺成本的重新评估
机译:聚乙二醇化G-CsF抑制血细胞耗竭,增加血小板,阻止脾肿大,并改善全身电离辐射后的存活率,但在照射与烧伤结合后不能